Successful Treatment with Triple Therapy of Amphotericin B, Voriconazole and Flucytosine on an AIDS Patients with Severe Cryptococcal Meningitis
A 35-year-old man (body weight = 63 kg) with AIDS complaining fever and headache after having commenced anti-retroviral therapy (ART) for a week was admitted to our hospital. Five lumbar punctures performed during 38 days could not confirm a cryptococcal meningitis (CM) based on staining or culture...
Main Authors: | Hu Zhi-liang, Wei Hong-xia, Yao Wen-hu, Yang Yong-feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2012-06-01
|
Series: | Infection International |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/ii.2012.1.issue-2/ii-2017-0017/ii-2017-0017.xml?format=INT |
Similar Items
-
Voriconazole as a secondary prophylaxis for cryptococcal meningitis during hematopoietic stem cell transplantation
by: Emiko Kashima, et al.
Published: (2021-01-01) -
Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
by: Lijun Xu, et al.
Published: (2019-09-01) -
MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
by: J Scriven, et al.
Published: (2013-09-01) -
Efficacy of amphotericin B in a fat emulsion for the treatment of cryptococcal meningitis in AIDS patients
by: Fernando Góngora Rubio, et al. -
Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
by: Jacqui Miot, et al.
Published: (2021-04-01)